BEFORE THE BELL-Rigel shares up after comments on drug

NEW YORK, July 9 (Reuters) - Shares of Rigel Pharmaceuticals (RIGL.O) rose 29 percent to $14.50 in premarket trading on Thursday, after the company said its arthritis drug was showing progress.

For details see [ID:nBNG491740]. (Reporting by Ryan Vlastelica; Editing by James Dalgleish)